358570 — GI Innovation Share Price
- KR₩542bn
- KR₩522bn
- KR₩5bn
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 19.44 | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | -81.19% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 11.08 | ||
Price to Tang. Book | 11.44 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 114 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -80.6% | ||
Return on Equity | -65.99% | ||
Operating Margin | -899.43% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | KR₩m | 3,513.61 | 11,016.79 | 5,600 | 3,500 | 5,318.85 | 198,000 | 63,000 | 10.92% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
GI Innovation Inc is a Korea-based company engaged in the research and development of next-generation immunotherapies based on fusion proteins. The Company is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- July 19th, 2017
- Public Since
- March 30th, 2023
- No. of Shareholders
- 16,992
- No. of Employees
- 81
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 44,214,811
- Address
- 167, Songpa-Daero, Songpa-Gu, SEOUL, 05855
- Web
- https://www.gi-innovation.com/
- Phone
- +82 24042003
- Auditors
- Samil Accounting Corp.
Similar to 358570
ABion
Korea Exchange - KOSDAQ
ABL Bio
Korea Exchange - KOSDAQ
Amicogen
Korea Exchange - KOSDAQ
AprilBio Co
Korea Exchange - KOSDAQ
AptaBio Therapeutics
Korea Exchange - KOSDAQ
FAQ
As of Today at 20:51 UTC, shares in GI Innovation are trading at KR₩12,260. This share price information is delayed by 15 minutes.
Shares in GI Innovation last closed at KR₩12,260 and the price had moved by -7.32% over the past 365 days. In terms of relative price strength the GI Innovation share price has underperformed the FTSE Developed Asia Pacific Index by -20.86% over the past year.
The overall consensus recommendation for GI Innovation is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreGI Innovation does not currently pay a dividend.
GI Innovation does not currently pay a dividend.
GI Innovation does not currently pay a dividend.
To buy shares in GI Innovation you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩12,260, shares in GI Innovation had a market capitalisation of KR₩542bn.
Here are the trading details for GI Innovation:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 358570
Based on an overall assessment of its quality, value and momentum GI Innovation is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in GI Innovation is KR₩23,250. That is 89.64% above the last closing price of KR₩12,260.
Analysts covering GI Innovation currently have a consensus Earnings Per Share (EPS) forecast of KR₩4,871 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like GI Innovation. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -15.51%.
As of the last closing price of KR₩12,260, shares in GI Innovation were trading +2.9% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The GI Innovation PE ratio based on its reported earnings over the past 12 months is 19.44. The shares last closed at KR₩12,260.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on GI Innovation's directors